JP2023175688A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023175688A5 JP2023175688A5 JP2023132463A JP2023132463A JP2023175688A5 JP 2023175688 A5 JP2023175688 A5 JP 2023175688A5 JP 2023132463 A JP2023132463 A JP 2023132463A JP 2023132463 A JP2023132463 A JP 2023132463A JP 2023175688 A5 JP2023175688 A5 JP 2023175688A5
- Authority
- JP
- Japan
- Prior art keywords
- patient
- gdc
- labc
- mbc
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063023501P | 2020-05-12 | 2020-05-12 | |
| US63/023,501 | 2020-05-12 | ||
| JP2022515505A JP2023500558A (ja) | 2020-05-12 | 2021-05-10 | Ｇｄｃ－９５４５及びｃｄｋ４／６阻害剤を含む併用療法を使用した乳がん治療 |
| PCT/US2021/031491 WO2021231250A1 (en) | 2020-05-12 | 2021-05-10 | Treatment of breast cancer using combination therapies comprising gdc-9545 and a cdk4/6 inhibitor |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022515505A Division JP2023500558A (ja) | 2020-05-12 | 2021-05-10 | Ｇｄｃ－９５４５及びｃｄｋ４／６阻害剤を含む併用療法を使用した乳がん治療 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023175688A JP2023175688A (ja) | 2023-12-12 |
| JP2023175688A5 true JP2023175688A5 (enExample) | 2025-12-16 |
Family
ID=76250442
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022515505A Withdrawn JP2023500558A (ja) | 2020-05-12 | 2021-05-10 | Ｇｄｃ－９５４５及びｃｄｋ４／６阻害剤を含む併用療法を使用した乳がん治療 |
| JP2023132463A Pending JP2023175688A (ja) | 2020-05-12 | 2023-08-16 | Ｇｄｃ－９５４５及びｃｄｋ４／６阻害剤を含む併用療法を使用した乳がん治療 |
| JP2024045217A Pending JP2024102045A (ja) | 2020-05-12 | 2024-03-21 | Ｇｄｃ－９５４５及びｃｄｋ４／６阻害剤を含む併用療法を使用した乳がん治療 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022515505A Withdrawn JP2023500558A (ja) | 2020-05-12 | 2021-05-10 | Ｇｄｃ－９５４５及びｃｄｋ４／６阻害剤を含む併用療法を使用した乳がん治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024045217A Pending JP2024102045A (ja) | 2020-05-12 | 2024-03-21 | Ｇｄｃ－９５４５及びｃｄｋ４／６阻害剤を含む併用療法を使用した乳がん治療 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US11918561B2 (enExample) |
| EP (1) | EP4149476A1 (enExample) |
| JP (3) | JP2023500558A (enExample) |
| KR (1) | KR20230009390A (enExample) |
| CN (2) | CN115551513B (enExample) |
| AU (1) | AU2021272100B2 (enExample) |
| CA (1) | CA3182018A1 (enExample) |
| IL (1) | IL298071A (enExample) |
| MX (1) | MX2022014133A (enExample) |
| TW (1) | TWI800827B (enExample) |
| WO (1) | WO2021231250A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2022222660A1 (en) * | 2021-02-16 | 2023-07-27 | Genentech, Inc. | Treatment of breast cancer using combination therapies comprising gdc-9545 and abemaciclib or ribociclib |
| KR20240163084A (ko) * | 2022-03-14 | 2024-11-18 | 제넨테크, 인크. | 유방암에 대한 복합 요법 |
| CN121337802B (zh) * | 2025-10-23 | 2026-04-14 | 安徽益普克医药科技发展有限公司 | 一种雌激素降解剂衍生物及其制备方法与用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105828822B (zh) * | 2013-08-14 | 2019-10-18 | 诺华股份有限公司 | 用于治疗癌症的组合疗法 |
| KR102358935B1 (ko) * | 2014-02-12 | 2022-02-04 | 가부시키가이샤 한도오따이 에네루기 켄큐쇼 | 전자 기기 |
| TWI874834B (zh) * | 2014-12-18 | 2025-03-01 | 瑞士商赫孚孟拉羅股份公司 | 四氫-吡啶并[3,4-b]吲哚雌激素受體調節劑及其用途 |
| KR20250152679A (ko) * | 2015-04-29 | 2025-10-23 | 래디어스 파마슈티컬스, 인코포레이티드 | 암을 치료하는 방법 |
| AU2017235450A1 (en) * | 2016-03-15 | 2018-08-16 | Merrimack Pharmaceuticals, Inc. | Methods for treating ER+, HER2-, HRG+ breast cancer using combination therapies comprising an anti-ErbB3 antibody |
| CR20200621A (es) * | 2018-06-21 | 2021-02-03 | Hoffmann La Roche | Formas sólidas de 3-((1r,3r)-1-(2,6-difluoro-4-((1-(3 fluoropropil)azetidin-3-il)amino)fenil)-3-(metil-1,3,4,9-tetrahidro-2h-pirido[3,4-b]indol-2-il)-2,2-difluoropropan-1-ol y procesos para preparar compuestos tricíclicos fusionados que comprenden un resto fenilo o piridinilo sustituido, incluidos métodos para su uso |
| JP7571006B2 (ja) | 2018-08-17 | 2024-10-22 | ジェネンテック， インコーポレイテッド | 乳がんの処置のための診断的および治療的方法 |
| JP7826068B2 (ja) * | 2022-03-11 | 2026-03-09 | 本田技研工業株式会社 | パワーユニット、及びパワーユニットを搭載した作業機 |
-
2021
- 2021-05-10 CN CN202180034978.8A patent/CN115551513B/zh active Active
- 2021-05-10 TW TW110116831A patent/TWI800827B/zh active
- 2021-05-10 IL IL298071A patent/IL298071A/en unknown
- 2021-05-10 CN CN202510482379.2A patent/CN120324434A/zh active Pending
- 2021-05-10 AU AU2021272100A patent/AU2021272100B2/en active Active
- 2021-05-10 KR KR1020227039518A patent/KR20230009390A/ko active Pending
- 2021-05-10 CA CA3182018A patent/CA3182018A1/en active Pending
- 2021-05-10 US US17/316,455 patent/US11918561B2/en active Active
- 2021-05-10 EP EP21729702.7A patent/EP4149476A1/en active Pending
- 2021-05-10 MX MX2022014133A patent/MX2022014133A/es unknown
- 2021-05-10 WO PCT/US2021/031491 patent/WO2021231250A1/en not_active Ceased
- 2021-05-10 JP JP2022515505A patent/JP2023500558A/ja not_active Withdrawn
-
2023
- 2023-08-16 JP JP2023132463A patent/JP2023175688A/ja active Pending
-
2024
- 2024-01-26 US US18/423,596 patent/US12303495B2/en active Active
- 2024-03-21 JP JP2024045217A patent/JP2024102045A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023175688A5 (enExample) | ||
| JP2024102045A5 (enExample) | ||
| CN1103589C (zh) | 调节人体性反应的方法 | |
| CN1277545C (zh) | 二膦酸类化合物在制备用于治疗与前列腺癌有关的骨转移瘤的药物中的用途 | |
| US5470883A (en) | Method of treating peripheral vasoconstriction with tamoxifen citrate | |
| JP2019529581A5 (enExample) | ||
| JP2022544485A5 (enExample) | ||
| TW202333675A (zh) | 用於治療癌症之組合療法之用途 | |
| JP2019529574A5 (enExample) | ||
| TW202304424A (zh) | 包含依維莫司和安森司群的組合 | |
| JP2019508476A5 (enExample) | ||
| JP2015517523A5 (enExample) | ||
| JP2018123168A (ja) | 癌療法における使用のためのトランス−クロミフェン | |
| JP2024542633A5 (enExample) | ||
| JP6743001B2 (ja) | シス−クロミフェンを用いたアンドロゲン除去療法によって生じるホットフラッシュ及び骨量減少の治療 | |
| JP2022543679A5 (enExample) | ||
| JP2023522415A5 (enExample) | ||
| CN1407890A (zh) | 牛皮癣的治疗 | |
| CN1929835A (zh) | 芳香酶抑制剂治疗－相关的骨质疏松症的治疗 | |
| JP2024506385A5 (enExample) | ||
| JP2022058873A5 (enExample) | ||
| CN101010074A (zh) | 选择性雌激素受体调节剂在制备用于治疗或预防雄激素缺乏的药物制剂中的用途 | |
| KR20090040453A (ko) | 파록세틴으로 체온 조절 기능 이상을 치료하는 방법 | |
| JP2024506347A5 (enExample) | ||
| TW201244732A (en) | Ezatiostat for treating multiple myeloma |